4-144116868-G-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_002099.8(GYPA):​c.343C>A​(p.Arg115Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000157 in 1,587,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000016 ( 0 hom. )

Consequence

GYPA
NM_002099.8 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -4.76
Variant links:
Genes affected
GYPA (HGNC:4702): (glycophorin A (MNS blood group)) Glycophorins A (GYPA) and B (GYPB) are major sialoglycoproteins of the human erythrocyte membrane which bear the antigenic determinants for the MN and Ss blood groups. In addition to the M or N and S or s antigens that commonly occur in all populations, about 40 related variant phenotypes have been identified. These variants include all the variants of the Miltenberger complex and several isoforms of Sta, as well as Dantu, Sat, He, Mg, and deletion variants Ena, S-s-U- and Mk. Most of the variants are the result of gene recombinations between GYPA and GYPB. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.044005036).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GYPANM_002099.8 linkuse as main transcriptc.343C>A p.Arg115Ser missense_variant 5/7 ENST00000641688.3 NP_002090.4
LOC105377460XR_002959803.2 linkuse as main transcriptn.5270+1639G>T intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GYPAENST00000641688.3 linkuse as main transcriptc.343C>A p.Arg115Ser missense_variant 5/7 NM_002099.8 ENSP00000493142 P4

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
152042
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000797
AC:
2
AN:
251000
Hom.:
0
AF XY:
0.00000737
AC XY:
1
AN XY:
135640
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000160
AC:
23
AN:
1435862
Hom.:
0
Cov.:
27
AF XY:
0.0000154
AC XY:
11
AN XY:
716216
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000184
Gnomad4 OTH exome
AF:
0.0000504
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
152042
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74272
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000193
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 22, 2023The c.343C>A (p.R115S) alteration is located in exon 5 (coding exon 5) of the GYPA gene. This alteration results from a C to A substitution at nucleotide position 343, causing the arginine (R) at amino acid position 115 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.41
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.0020
DANN
Benign
0.80
DEOGEN2
Benign
0.033
.;T;T;.;.;.;.;.;.;T;T;.;.;.
Eigen
Benign
-2.2
Eigen_PC
Benign
-2.5
FATHMM_MKL
Benign
0.0022
N
LIST_S2
Benign
0.68
T;.;T;T;T;.;.;T;T;T;T;T;T;T
M_CAP
Benign
0.0057
T
MetaRNN
Benign
0.044
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.80
T
MutationTaster
Benign
1.0
N;N;N;N;N;N;N;N
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-2.3
.;.;N;.;N;.;.;.;.;.;D;D;N;D
REVEL
Benign
0.045
Sift
Benign
0.30
.;.;T;.;T;.;.;.;.;.;T;T;T;T
Sift4G
Benign
0.18
T;.;T;.;T;.;T;.;.;.;T;T;T;T
Polyphen
0.077, 0.14
.;.;.;.;.;.;.;.;.;.;B;B;B;.
Vest4
0.19
MutPred
0.41
.;Loss of MoRF binding (P = 0.0157);Loss of MoRF binding (P = 0.0157);Loss of MoRF binding (P = 0.0157);.;.;.;.;.;.;.;.;.;.;
MVP
0.014
MPC
0.061
ClinPred
0.095
T
GERP RS
-9.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.043

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs572116498; hg19: chr4-145038021; API